FDA's Center for Biologics Evaluation and Research regulates the following products: allergenic extracts, monoclonal antibodies, biotech derived therapeutics, somatic cell and gene therapy, xenotransplantation, tissues, some devices, whole blood, blood components, blood derivatives, and vaccines.
The Pew Charitable Trusts and ISPE Release New Joint Drug Shortages Study
Thursday, 12 Jan 2017 13.01
ISPE Good Practice Guide: Sampling for Pharmaceutical Water, Steam, and Process Gases
Wednesday, 11 Jan 2017 14.01
Chairman’s Chatter – Starting Strong in 2017
Tuesday, 10 Jan 2017 15.01